Abstract

On Being a Patient4 September 2018Michael's TestimonialMichael M. Danielson and Karine Dubé, DrPHMichael M. DanielsonSan Diego, California (M.M.D.)Search for more papers by this author and Karine Dubé, DrPHUniversity of Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina (K.D.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M18-1719 Audio Reading - “Michael's Testimonial” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Michael's Testimonial," by M.M. Danielson and K. Dubé. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail I have very strong feelings about California's End of Life Option Act. When I was diagnosed with ALS last summer, one of the most comforting aspects was that I was going to be in control of my end. I was relieved to know that I did not have to suffer needlessly and indeterminately. The End of Life Option Act afforded me and other terminally ill people the option—and that is a very important word—to have dignity and compassion at the end of our lives. That gave me a great deal of comfort in the past year.I was very upset ... Author, Article, and Disclosure InformationAffiliations: San Diego, California (M.M.D.)University of Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina (K.D.)Corresponding Author: Karine Dubé, DrPH, University of Carolina Gillings School of Global Public Health, 4108 McGavran-Greenberg, Chapel Hill, NC 27516; e-mail, [email protected]unc.edu. PreviousarticleNextarticle Advertisement Audio Reading - “Michael's Testimonial” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Michael's Testimonial," by M.M. Danielson and K. Dubé. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ FiguresReferencesRelatedDetailsSee AlsoMichael's Testimonial Roger S. LaBonte Michael's Testimonial Stephen Strum Michael's Testimonial Michael M. Danielson and Karine Dubé Michael's Testimonial David Killoran Metrics Cited byLessons learned from the Last Gift study: ethical and practical challenges faced while conducting HIV cure-related research at the end of lifeThe wish to die and hastening death in amyotrophic lateral sclerosis: A scoping review“My Death Will Not [Be] in Vain”: Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life“[It] is now my responsibility to fulfill that wish:” Clinical and rapid autopsy staff members’ experiences and perceptions of HIV reservoir research at the end of lifeMedical Assistance in Death as a Unique Opportunity to Advance Human Immunodeficiency Virus Cure ResearchParticipating in Human Immunodeficiency Virus Cure Research at the End of LifeMichael's TestimonialRoger S. LaBonte, MDMichael's TestimonialStephen Strum, MDMichael's TestimonialDavid Killoran, Esq 4 September 2018Volume 169, Issue 5Page: 349KeywordsAnxietyBrainEmotionsGlobal healthMortalityPrevention, policy, and public healthResidency ePublished: 4 September 2018 Issue Published: 4 September 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.